Dr Reddy’s Laboratories announced today that it has launched Moxifloxacin Hydrochloride Tablets 400 mg, a therapeutic equivalent generic version of Avelox® (moxifloxacin HCl) tablets 400 mg in the US market. It is an anti-bacterial that is useful for adults in treating acute bacterial sinusitis, bronchitis, skin and abdominal infections.
Dr Reddy’s launches drug in US
Published on
March 5, 2014 17:41